Skip to content

Search

Showing results for "clinical trials"

New website provides tools and resources for parents of gender diverse children and young people

Transforming Families is providing evidence-based resources to help support the mental wellbeing of young people questioning their gender identity, or who identify as trans or gender diverse.

An evening for the future of autism

Join Dr Andrew Whitehouse, head of Developmental Disorders research at The Kids, as he shares with you his vision for autism research.

Defective cell migration as a mechanism of dysregulated asthmatic airway repair

The findings from this study show that in children with asthma this protective barrier is different from children without asthma.

KINDEE: Kids INfections and Day care’s Effects on the lungs in those born Early

Over the last 40 years medical advances in the care of newborn babies has resulted in more children surviving very early “preterm” birth than ever before.

Celebrate Book Week with Us!

Join us for stories, imagination and connection in the Discovery Centre

Atypical Presentations

We investigated the factors that may affect the age at diagnosis for girls and woman with Rett syndrome.

Sleep problems in Rett syndrome

Using information from the Australian Rett Syndrome study, we examined the frequency of a range of sleep issues and variation by agegroup or gene abnormalities.

A general factor for trust?: Testing latent factor structures of trust across institutional and interpersonal contexts

The literature is replete with multi-dimensional self-report assessments of trust. It is not clear whether these dimensions are statistically distinguishable across institutional and interpersonal contexts, respectively.

AI succeeds in diagnosing rare diseases

Timo Lassmann BSc (Hons) MSc PhD Feilman Fellow; Head, Precision Health Research and Head, Translational Intelligence timo.lassmann@thekids.org.au

MetaNeb Versus Usual Care During Exacerbations of Cystic Fibrosis: An RCT

During exacerbations, when symptom and treatment burden are increased, individuals with cystic fibrosis (CF) are likely to prefer airway clearance techniques (ACTs) that require minimal effort. Therefore, in adults with CF who were hospitalised with an exacerbation, we sought to compare the effect of the MetaNeb with usual ACTs on respiratory function and expectorated sputum.